目前和新兴的治疗策略对于有限和广泛的小细胞肺癌
Walid Shalata1,2, Rashad Naamneh2,3, Wenad Najjar4
1The Legacy Heritage Cancer Center, Larry Norton Institute, Soroka Medical Center, Beer-Sheva 8410501, Israel.
Medical sciences (Basel, Switzerland)
|August 22, 2025
概括
免疫疗法改变了小细胞肺癌 (SCLC) 的治疗方法,为扩散阶段的疾病制定了新的标准. 未来的研究重点是生物标志物和BiTE等新疗法, 以进一步改善这种侵袭性癌症的结果.
科学领域:
- 医学瘤学
- 肺病学
- 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有不良预后的侵袭性神经内分泌瘤.
- 在历史上,广泛的SCLC (ES-SCLC) 的治疗选择是有限的.
- 最近的进展显著改变了SCLC的治疗环境.
研究的目的:
- 综合目前SCLC治疗标准的证据.
- 审查关键临床试验和国际指导方针.
- 提供对不断发展的SCLC治疗领域的全面概述.
主要方法:
- 来自关键临床试验和网络元分析的合成数据.
- 评估国家综合癌症网络 (NCCN) 和欧洲医学瘤学会 (ESMO) 的指导方针.
- 对SCLC的第一线化疗免疫疗法进行全面分析.
主要成果:
- 与巩固性免疫治疗同时进行化学放射治疗 (ccRT) 是有限阶段SCLC (LS-SCLC) 的标准,并进行预防性皮辐射 (PCI) 重新评估.
- 免疫检查点抑制剂 (ICI) 与乙化疗相结合,代表了ES-SCLC的新标准,产生了生存益处.
- 在ADRIATIC试验中,巩固性免疫疗法在LS-SCLC中显示出有效性.
结论:
- 免疫治疗的整合,特别是在ES-SCLC中,确立了新的标准,改善了患者的治疗结果.
- 未来的方向包括识别预测生物标志物和开发新型疗法,如Bi-specific T-cell Engagers (BiTE) 和抗体与药物结合物.
- 持续的研究有望进一步改善SCLC的预后.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K